Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
第一著者: | Tamanna, Mst. Taskia |
---|---|
その他の著者: | Sharmin, Dr. Sabrina |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
Brac University
2023
|
主題: | |
オンライン・アクセス: | http://hdl.handle.net/10361/18146 |
類似資料
-
Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
著者:: Hassan, Md. Muhtaz
出版事項: (2020) -
Role of protein’s and future treatment options for Alzheimer’s Disease
著者:: Islam, Md. Irfath
出版事項: (2023) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
著者:: Alim, Abdul
出版事項: (2023) -
Marine compounds in the treatment of Alzheimer’s disease
著者:: Parveen, Sanjana
出版事項: (2022) -
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
著者:: Tabassum, Nadira
出版事項: (2024)